Increasing Decision Quality for Men With Lower Urinary Tract Symptoms
NCT ID: NCT04851275
Last Updated: 2021-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2019-04-15
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Association of Baseline Characteristics of Male Patients Presented With LUTS and Long Term Clinical Outcomes
NCT04764903
Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice
NCT00111592
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
NCT05508165
Identification and Treatment of Men With BPH in the Primary Care Setting
NCT00211640
BE Technologies Mobile Uroflowmetry Validation Study
NCT04599283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study recruited 60 multi-ethnic Asian men aged ≥50 years with moderate-to-severe LUTS (International Prostate Symptoms Score≥8 and/or QOL≥3) in a Singapore public primary care clinic. Men used the VAUS to report their symptoms. 60 men were randomly assigned to PCPs trained in SDM in the intervention group (n=30) and the other 30 to the control group (PCPs without SDM-training). Patient-physician dyad decision quality was measured using the validated SDMQ-9 (patient) and SDMQ-Doc (physician) questionnaires.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Shared decision making for men with lower urinary tract symptoms
Participants used the Visual Analogue Uroflowmetry Score so report their symptoms and were attended by Primary Care Physicians trained in shared decision making
Physicians trained in shared decision making
Physicians in this group were trained in shared decision making
No shared decision making for men with lower urinary tract symptoms
Participants did not use the Visual Analogue Uroflowmetry Score to report their symptoms and received usual care by Primary Care Physicians not trained in shared decision making
Physicians were not trained in shared decision making
Physicians did not receive training in shared decision making
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physicians trained in shared decision making
Physicians in this group were trained in shared decision making
Physicians were not trained in shared decision making
Physicians did not receive training in shared decision making
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have moderate-to-severe LUTS and/or poor quality of life (QOL) as assessed by the validated International Prostate Symptom Score (IPSS) of eight or more and/or its individual QOL score of three or more
* men of any local Asian ethnicity and were willing to provide written consent
* can communicate with their allocated PCP in either of the three main local languages; English, Mandarin or Malay.
Exclusion Criteria
* urinary incontinence requiring diapers
* anuria due to any renal pathology
* gross hematuria
* acute urinary retention
* symptoms consistent with an acute urinary tract infection
* existing treatment of LUTS or other prostate pathology
* visual or hearing impairment which render men incapable of understanding the study procedure and providing informed consent
* men unwilling to discuss their LUTS treatment options with their PCP
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Singapore General Hospital
OTHER
SingHealth Polyclinics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tan Ngiap Chuan, MBBS
Role: STUDY_DIRECTOR
Singhealth polyclinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haidee Ngu
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tiwari R, Ng MY, Neo SH, Mangat R, Ho H. Prospective validation of a novel visual analogue uroflowmetry score (VAUS) in 1000 men with lower urinary tract symptoms (LUTS). World J Urol. 2020 May;38(5):1267-1273. doi: 10.1007/s00345-019-02909-1. Epub 2019 Aug 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/3106
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.